Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort

Thierry Morin1, Alexandre Pariente, Pierre Lahmek

  • 1Centre Hospitalier de Bigorre, 65013 Tarbes, France. tmorin@ch-tarbes-vic.fr

Insights

Acute hepatitis C (AHC) is primarily transmitted through drug use and sexual contact. A three-month observation period can help avoid unnecessary treatment for many patients with AHC.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Acute hepatitis C (AHC) is a significant public health concern.
  • Understanding the epidemiology and transmission patterns of AHC is crucial for effective prevention and management.
  • Previous studies have provided insights, but large-scale, prospective data from diverse populations remain valuable.

Purpose of the Study:

  • To analyze the epidemiology, transmission modes, clinical course, and outcomes of a large cohort of patients diagnosed with acute hepatitis C in France.
  • To identify factors associated with spontaneous viral clearance in AHC.
  • To evaluate the effectiveness of antiviral treatments for AHC.

Main Methods:

  • A prospective, multicenter, observational study was conducted.
  • 126 patients with AHC were enrolled between 1999 and 2007.
  • Data on demographics, transmission risk factors, clinical presentation, viral clearance, and treatment outcomes were collected.

Main Results:

  • Drug use (38%) and sexual contact (21%) were the predominant suspected transmission routes for hepatitis C virus (HCV).
  • Spontaneous viral clearance occurred in 40% of untreated patients observed for 3 months; jaundice and nosocomial/occupational transmission predicted clearance.
  • Antiviral therapy, particularly 24 weeks of pegylated interferon-alpha alone, demonstrated high efficacy (74% sustained viral response in HCV monoinfected patients).

Conclusions:

  • Acute hepatitis C is relatively rare, with drug use and sexual contact being the primary modes of transmission.
  • A 3-month observation period post-diagnosis can prevent unnecessary treatment in approximately 40% of patients.
  • Antiviral treatments are highly effective, with a 24-week course of pegylated interferon-alpha alone representing a favorable therapeutic option.
Abstract